CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
Author:
Publisher
Elsevier BV
Subject
Urology
Reference64 articles.
1. Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostate;Amato;Urol Oncol,1995
2. Oral cyclophosphamide (CTX) for hormone refractory prostate cancer (HRPC);Abell;Proc Am Soc Clin Oncol,1995
3. Mechanisms of action and clinical uses of estramustine;Benson;Cancer Invest,1990
4. Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: A Southwest Oncology Group study;Blumenstein;J Urol,1993
5. Phase II study of estramustine and vinorelbine in hormone refractory prostate carcinoma patients;Carles;Acta Oncol,1998
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and emerging treatments in the management of castration-resistant prostate cancer;Expert Review of Anticancer Therapy;2012-07
2. Final Report on Low-Dose Estramustine Phosphate (EMP) Monotherapy and Very Low-Dose EMP Therapy combined with LH-RH Agonist for Previously Untreated Advanced Prostate Cancer;Aktuelle Urologie;2010-01
3. Anticancer Effect of Combination Therapy of VP16 and Fosfesterol in Hormone-Refractory Prostate Cancer;American Journal of Clinical Oncology;2008-04
4. Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles;British Journal of Cancer;2006-05-09
5. A Bystander Effect in Alpha-Particle Irradiations of Human Prostate Tumor Cells;Radiation Research;2005-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3